Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Choosing Variant Interpretation Tools for Clinical Applications: Context Matters

  • Aguirre, Josu
  • Padilla Sirera, Natàlia
  • Ozkan, Selen
  • Riera, Casandra
  • Feliubadaló, Lidia
  • De la Cruz Montserrat, Fco. Xavier
Clinical variant interpretation; Healthcare costs; Pathogenicity prediction, Interpretación de variantes clínicas; Costes sanitarios; Predicción de patogenicidad, Interpretació de variants clíniques; Despeses sanitàries; Predicció de patogenicitat, Pathogenicity predictors are computational tools that classify genetic variants as benign or pathogenic; this is currently a major challenge in genomic medicine. With more than fifty such predictors available, selecting the most suitable tool for clinical applications like genetic screening, molecular diagnostics, and companion diagnostics has become increasingly challenging. To address this issue, we have developed a cost-based framework that naturally considers the various components of the problem. This framework encodes clinical scenarios using a minimal set of parameters and treats pathogenicity predictors as rejection classifiers, a common practice in clinical applications where low-confidence predictions are routinely rejected. We illustrate our approach in four examples where we compare different numbers of pathogenicity predictors for missense variants. Our results show that no single predictor is optimal for all clinical scenarios and that considering rejection yields a different perspective on classifiers., This work was supported by research grants SAF2016-80255-R from the Spanish Ministerio de Economía y Competitividad (MINECO), PID2019-111217RB-I00 and TED2021-130342B-I00 from the Spanish Ministerio de Ciencia e Innovación, and by the European Regional Development Fund (ERDF) through the Interreg program POCTEFA (Pirepred, EFA086/15).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

QAFI: a novel method for quantitative estimation of missense variant impact using protein-specific predictors and ensemble learning

  • Ozkan, Selen
  • Padilla Sirera, Natàlia
  • De la Cruz Montserrat, Fco. Xavier
Seqüenciació de nova generació; Diagnòstic genètic; Medicina de precisió, Next-generation sequencing; Genetic diagnostic; Precision medicine, Secuenciación de nueva generación; Diagnóstico genético; Medicina de precisión, Next-generation sequencing (NGS) has revolutionized genetic diagnostics, yet its application in precision medicine remains incomplete, despite significant advances in computational tools for variant annotation. Many variants remain unannotated, and existing tools often fail to accurately predict the range of impacts that variants have on protein function. This limitation restricts their utility in relevant applications such as predicting disease severity and onset age. In response to these challenges, a new generation of computational models is emerging, aimed at producing quantitative predictions of genetic variant impacts. However, the field is still in its early stages, and several issues need to be addressed, including improved performance and better interpretability. This study introduces QAFI, a novel methodology that integrates protein-specific regression models within an ensemble learning framework, utilizing conservation-based and structure-related features derived from AlphaFold models. Our findings indicate that QAFI significantly enhances the accuracy of quantitative predictions across various proteins. The approach has been rigorously validated through its application in the CAGI6 contest, focusing on ARSA protein variants, and further tested on a comprehensive set of clinically labeled variants, demonstrating its generalizability and robust predictive power. The straightforward nature of our models may also contribute to better interpretability of the results., This work was supported by the Ministerio de Ciencia e Innovación de España through grants PID2019-111217RB-I00 and PID2022-142753OB-I00, both co-funded by the European Regional Development Fund (FEDER); and by grant TED2021-130342B-I00, funded by the Next Generation EU funds.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

QAFI: a novel method for quantitative estimation of missense variant impact using protein-specific predictors and ensemble learning

  • Ozkan, Selen
  • Padilla Sirera, Natàlia
  • De la Cruz Montserrat, Fco. Xavier
Seqüenciació de nova generació; Diagnòstic genètic; Medicina de precisió, Next-generation sequencing; Genetic diagnostic; Precision medicine, Secuenciación de nueva generación; Diagnóstico genético; Medicina de precisión, Next-generation sequencing (NGS) has revolutionized genetic diagnostics, yet its application in precision medicine remains incomplete, despite significant advances in computational tools for variant annotation. Many variants remain unannotated, and existing tools often fail to accurately predict the range of impacts that variants have on protein function. This limitation restricts their utility in relevant applications such as predicting disease severity and onset age. In response to these challenges, a new generation of computational models is emerging, aimed at producing quantitative predictions of genetic variant impacts. However, the field is still in its early stages, and several issues need to be addressed, including improved performance and better interpretability. This study introduces QAFI, a novel methodology that integrates protein-specific regression models within an ensemble learning framework, utilizing conservation-based and structure-related features derived from AlphaFold models. Our findings indicate that QAFI significantly enhances the accuracy of quantitative predictions across various proteins. The approach has been rigorously validated through its application in the CAGI6 contest, focusing on ARSA protein variants, and further tested on a comprehensive set of clinically labeled variants, demonstrating its generalizability and robust predictive power. The straightforward nature of our models may also contribute to better interpretability of the results., This work was supported by the Ministerio de Ciencia e Innovación de España through grants PID2019-111217RB-I00 and PID2022-142753OB-I00, both co-funded by the European Regional Development Fund (FEDER); and by grant TED2021-130342B-I00, funded by the Next Generation EU funds.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Choosing Variant Interpretation Tools for Clinical Applications: Context Matters

  • Aguirre, Josu
  • Padilla Sirera, Natàlia
  • Ozkan, Selen
  • Riera, Casandra
  • Feliubadaló, Lidia
  • De la Cruz Montserrat, Fco. Xavier
Clinical variant interpretation; Healthcare costs; Pathogenicity prediction, Interpretación de variantes clínicas; Costes sanitarios; Predicción de patogenicidad, Interpretació de variants clíniques; Despeses sanitàries; Predicció de patogenicitat, Pathogenicity predictors are computational tools that classify genetic variants as benign or pathogenic; this is currently a major challenge in genomic medicine. With more than fifty such predictors available, selecting the most suitable tool for clinical applications like genetic screening, molecular diagnostics, and companion diagnostics has become increasingly challenging. To address this issue, we have developed a cost-based framework that naturally considers the various components of the problem. This framework encodes clinical scenarios using a minimal set of parameters and treats pathogenicity predictors as rejection classifiers, a common practice in clinical applications where low-confidence predictions are routinely rejected. We illustrate our approach in four examples where we compare different numbers of pathogenicity predictors for missense variants. Our results show that no single predictor is optimal for all clinical scenarios and that considering rejection yields a different perspective on classifiers., This work was supported by research grants SAF2016-80255-R from the Spanish Ministerio de Economía y Competitividad (MINECO), PID2019-111217RB-I00 and TED2021-130342B-I00 from the Spanish Ministerio de Ciencia e Innovación, and by the European Regional Development Fund (ERDF) through the Interreg program POCTEFA (Pirepred, EFA086/15).